Winway Health Desk
Biogen teams up with Sangamo in gene therapy deal worth up...
A large biotech is partnering with a firm developing cell and gene therapies on treatments for neurological diseases like Alzheimer’s and Parkinson’s.
Cambridge, Massachusetts-based Biogen...
Biohaven set to take on Allergan, Lilly with new migraine med...
With a new FDA nod for migraine medicine Nurtec ODT, Biohaven will be going up against serious marketing muscle from Allergan and Eli Lilly. But the company is optimistic...
Nominate Champions In Senior Living Design
Healthcare Design’s sister magazine, Environments for Aging, which serves professionals involved in the planning, design, and construction of senior living communities, is accepting nominations...
Three drug development strategies to combat 2019 novel coronavirus
Posted on February 28th, 2020 by Dr. Anton Yuryev in...
Can Testosterone Treatment Alleviate Depression Symptoms? Studies Say Yes!
Did you know that more than 250 million people have depressive symptoms all over the world? This mental disorder can affect both men and...
FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine...
FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine in Adults
NEW HAVEN, Conn., Feb. 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company...
Senators threaten to subpoena Cigna in insulin cost probe
Senate Finance Committee leaders have threatened to subpoena Cigna if it doesn’t turn over information on how it negotiates insulin costs. The request is...
Who were biopharma’s Q4 growth stars? Vertex, thanks to a new...
Several of the industry's top players turned in a strong performance in the fourth quarter, growing revenues at high single-digit rates, an analysis shows. Others?...
Esperion notches 2nd FDA approval with cholesterol-lowering combo Nexlizet
Esperion, aiming to reconfigure the cholesterol-lowering market, notched its first FDA approval last week for a novel drug expected to hit shelves at a...
New CDMO allows Acacia Pharma to win FDA approval of nausea...
Popular logic says you never switch horses, or CDMOs, in the middle of the stream. Biotch Acacia Pharma had to do just that to...
